e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Epigenetics and pulmonary diseases in the horizon of precision medicine: a review
Giuditta Benincasa, Dawn L. DeMeo, Kimberly Glass, Edwin K. Silverman, Claudio Napoli
Source:
Eur Respir J, 57 (6) 2003406; 10.1183/13993003.03406-2020
Journal Issue:
June
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Giuditta Benincasa, Dawn L. DeMeo, Kimberly Glass, Edwin K. Silverman, Claudio Napoli. Epigenetics and pulmonary diseases in the horizon of precision medicine: a review. Eur Respir J, 57 (6) 2003406; 10.1183/13993003.03406-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
The best papers in the ERJ: paediatric pulmonary diseases
Source: Virtual Congress 2020 – The European Respiratory Journal editor's view: our best papers of last year
Year: 2020
Late Breaking Abstract - Idiopathic Pulmonary Fibrosis – a worldwide review of ‘real’ life’ practice: experience from a treatment feasibility review in 41 countries
Source: International Congress 2018 – ILDs: From bench to bedside
Year: 2018
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
Source: Eur Respir J, 53 (1) 1801887; 10.1183/13993003.01887-2018
Year: 2019
Pathogenesis of ILDs, basic research year in review
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019
Pathogenesis of ILDs, basic research year in review
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2019
Precision medicine in airway diseases: moving to clinical practice
Source: Eur Respir J, 50 (4) 1701655; 10.1183/13993003.01655-2017
Year: 2017
Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance?
Source: Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020
Year: 2020
Paediatric pulmonary hypertension: monitoring progress and identifying unmet needs
Source: Eur Respir Rev 2009; 18: 18-23
Year: 2009
Diagnosing asthma in the era of personalised medicine: biology, physiology and imaging
Source: Virtual Congress 2021 – Precision medicine in asthma and COPD
Year: 2021
Proposed new pulmonary hypertension definition: is 4 mm(Hg) worth re-writing medical textbooks?
Source: Eur Respir J, 53 (3) 1900197; 10.1183/13993003.00197-2019
Year: 2019
Diagnosis of interstitial lung diseases and impact of guidelines: an issue only for pulmonologists?
Source: Annual Congress 2007 - Controversies in the management of interstitial lung diseases
Year: 2007
Late Breaking Abstract - The humanistic burden of asthma patients uncontrolled on ICS-LABA: a systematic literature review
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
COVID-19 and COPD: a narrative review of the basic science and clinical outcomes
Source: Eur Respir Rev, 29 (158) 200199; 10.1183/16000617.0199-2020
Year: 2020
Reading list SW11 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects
Source: International Congress 2016 – SW11 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects
Year: 2016
Reading list SW15 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects
Source: International Congress 2016 – SW15 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects
Year: 2016
Treatable traits: toward precision medicine of chronic airway diseases
Source: Eur Respir J 2016; 47: 410-419
Year: 2016
Perspectives of therapeutic innovation from current progress in the pathobiology of pulmonary hypertension
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020
Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era
Source: Eur Respir Rev, 27 (148) 180004; 10.1183/16000617.0004-2018
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept